| Literature DB >> 28991218 |
Rémy B Teponno1,2, Sara R Noumeur3,4,5, Soleiman E Helaly6,7, Stephan Hüttel8, Daoud Harzallah9, Marc Stadler10.
Abstract
Extracts from an endophytic fungus isolated from the roots of the Algerian plant Globularia alypum showed prominent antimicrobial activity in a screening for novel antibiotics. The producer organism was identified as Dendrothyrium variisporum by means of morphological studies and molecular phylogenetic methods. Studies on the secondary metabolite production of this strain in various culture media revealed that the major components from shake flasks were massarilactones D (1) and H (2) as well as two new furanone derivatives for which we propose the trivial names (5S)-cis-gregatin B (3) and graminin D (4). Scale-up of the fermentation in a 10 L bioreactor yielded massarilactone D and several further metabolites. Among those were three new anthranilic acid derivatives (5-7), two known anthranilic acid analogues (8 and 9) and three cyclopeptides (10-12). Their structures were elucidated on the basis of extensive spectroscopic analysis (1D- and 2D-NMR), high-resolution mass spectrometry (HRESIMS), and the application of the modified Mosher's method. The isolated metabolites were tested for antimicrobial and cytotoxic activities against various bacteria, fungi, and two mammalian cell lines. The new Metabolite 5 and Compound 9 exhibited antimicrobial activity while Compound 9 showed cytotoxicity activity against KB3.1 cells.Entities:
Keywords: Dendrothyrium variisporum; Montagnulaceae; anthranilic acid derivatives; antimicrobial activity; cytotoxicity; fermentation; furancarboxylic acid derivatives
Mesh:
Substances:
Year: 2017 PMID: 28991218 PMCID: PMC6151570 DOI: 10.3390/molecules22101674
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Structures of secondary metabolites isolated from Dendrothyrium variisporum.
13C- and 1H-NMR spectroscopic data of Compounds 3 and 4 (175 and 700 MHz, resp.; CDCl3; δ in ppm).
| Position | 3 | 4 | ||
|---|---|---|---|---|
| 2 | 195.6, C | / | 184.3, C | / |
| 3 | 106.8, C | / | 104.3, C | / |
| 4 | 197.8, C | / | 198.2, C | / |
| 5 | 91.4, C | / | 90.7, C | / |
| 1′ | 127.6, CH | 5.63, d (15.5) | 128.2, CH | 5.65, d (15.5) |
| 2′ | 126.5, CH | 6.59, ddd (15.5, 11.2, 1.3) | 126.5, CH | 6.59, ddd (15.5, 11.2, 1.3) |
| 3′ | 126.2, CH | 5.90, t (11.2) | 126.3, CH | 5.90, t (11.2) |
| 4′ | 136.9, CH | 5.53, d (10.8, 7.7) | 136.7, CH | 5.52, dt (10.8, 7.7) |
| 5′ | 21.2, CH2 | 2.21, m | 21.1, CH2 | 2.19, m |
| 6′ | 14.1, CH3 | 1.01, t (7.3) | 14.1, CH3 | 1.00, t (7.3) |
| 1′′ | 121.6, CH | 7.41, dt (15.9, 1.7) | ||
| 2′′ | 145.1, CH | 7.21, dt (15.9, 7.3) | ||
| 3′′ | 42.9, CH2 | 2.55, m | ||
| 4′′ | 67.0, CH | 4.08, m | ||
| 5′′ | 23.6, CH3 | 1.31, d (6.2) | ||
| 1′′′ | 163.4, C | / | 163.4, C | / |
| Me-5 | 22.5, CH3 | 1.56, s | 22.5, CH3 | 1.58, s |
| OMe | 51.6, CH3 | 3.83, s | 51.7, CH3 | 3.85, s |
Figure 2Selected HMBC correlations for Compounds 3 and 4.
Figure 3ECD spectra of Compounds 3 and 4 in ethanol.
Figure 4Δδ values (ppm) for the C-4′′ MTPA esters of Compound 4.
MIC [μg/mL] values of Compounds 1, 2, 4–12 against the tested microorganisms.
| Test Organism | MIC (μg/mL) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | References | |
| n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | 16.66 n | |
| n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | 8.33 n | |
| n.a. | n.a. | n.a. | 33.33 | n.a. | n.a. | n.a. | 16.66 | n.a. | n.a. | n.a. | 16.66 n | |
| n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | 16.66 n | |
| n.a. | n.a. | n.a. | 66.67 | n.a. | n.a. | n.a. | 33.33 | n.a. | n.a. | n.a. | 2.08 n | |
| n.a. | n.a. | n.a. | 16.66 | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | 0.40 o | |
| n.a. | n.a. | n.a. | 8.33 | n.a. | n.a. | n.a. | 66.67 | n.a. | n.a. | n.a. | 4.16 o | |
| n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | 3.33 o | |
| n.a. | n.a. | n.a. | 66.67 | n.a. | n.a. | n.a. | 66.67 | n.a. | n.a. | n.a. | 0.10 o | |
| n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | 2.08 k | |
| n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | 0.40 o | |
| n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | n.a. | 0.52 g | |
n.a.: No Activity, g Gentamycin 1 mg/mL, k Kanamycin 10 mg/mL, n Nystatin 1 mg/mL, o Oxytetracyclin 1 mg/mL.
13C- and 1H-NMR spectroscopic data of Compounds 5–7 in CD3OD.
| Position | 5 a | 6 a | 7 c | |||
|---|---|---|---|---|---|---|
| δC | ||||||
| 1 | 115.0, C | / | 111.7, C | / | 112.3, C | / |
| 2 | 137.5, C | / | 152.5, C | / | 151.9, C | / |
| 3 | 147.8, C | / | 118.2, CH | 6.77, dd (8.3, 1.0) | 118.4, CH | 6.78, dd (8.3, 1.0) |
| 4 | 119.5, CH | 6.90, dd (7.8, 1.4) | 135.4, CH | 7.25, ddd (8.5, 7.0, 1.6) | 135.2, CH | 7.26, ddd (8.5, 7.1, 1.6) |
| 5 | 119.0, CH | 6.66, t (7.9) | 117.2, CH | 6.60, ddd (8.1, 7.1, 1.1) | 117.5, CH | 6.62, ddd (8.2, 7.1, 1.1) |
| 6 | 122.8, CH | 7.35, dd (8.1, 1.4) | 132.2, CH | 7.83, dd ( 8.1, 1.6) | 132.2, CH | 7.81, dd ( 8.1, 1.6) |
| 7 | 169.2, C | / | 169.3, C | / | 169.6, C | / |
| 1′ | 139.7, C | / | 138.2, C | / | 62.4, CH2 | 4.41, t (7.0) |
| 2′ | 130.2, CH | 7.30, m b | 129.2, CH | 7.44, dd (8.0, 0.9) | 43.0, CH2 | 1.94, t (7.0) |
| 3′ | 129.7, CH | 7.30, m b | 129.7, CH | 7.38, td (7.1, 1.6) | 70.6, C | / |
| 4′ | 127.7, CH | 7.22, m | 129.3, CH | 7.31, m | 29.8, CH3 | 1.28, s |
| 5′ | 129.7, CH | 7.30, m b | 129.7, CH | 7.38, td (7.1, 1.6) | 29.8, CH3 | 1.28, s |
| 6′ | 130.2, CH | 7.30, m b | 129.2, CH | 7.44, dd (8.0, 0.9) | ||
| 7′ | 36.3, CH2 | 3.06, t (6.9) | 67.1, CH2 | 5.31, s | ||
| 8′ | 66.5, CH2 | 4.48, t (6.9) | ||||
a 175 and 700 MHz, resp.; b Overlapped; c 125 and 500 MHz, resp.
Figure 5Selected HMBC correlations for Compounds 5–7.
Cytotoxic effect (IC50) of Compounds 1, 2, and 4–12 against two cancer cell lines.
| IC50 (μg/mL) | IC50 (ng/mL) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cell Line | 1 | 2 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | Epothilone B |
| KB3.1 | n.a. | n.a. | 18 | 18 | n.a. | n.a. | n.a. | 8.8 | n.a. | n.a. | n.a. | 0.052 |
| L929 | n.a. | n.a. | 19 | no | n.a. | n.a. | n.a. | n.o. | n.a. | n.a. | n.a. | 1.4 |
n.a.: Not active; no: IC50 not obtained.